✦ LIBER ✦

Phase I dose escalation study of bortezomib in combination with lenalidomide in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)

✍ Scribed by Attar, Eyal C.; Amrein, Philip C.; Fraser, James W.; Fathi, Amir T.; McAfee, Steven; Wadleigh, Martha; DeAngelo, Daniel J.; Steensma, David P.; Stone, Richard M.; Foster, Julia; Neuberg, Donna; Ballen, Karen K.

Book ID: 123169948
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 390 KB
Volume: 37
Category: Article
ISSN: 0145-2126
DOI: 10.1016/j.leukres.2013.05.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase I Trial of Lenalidomide in Combi

A Phase I Trial of Lenalidomide in Combination with Intermediate Dose Cytarabine (IDC) in Relapsed or Refractory Acute Myeloid Leukemia (AML) Patients

✍ Vigil, Carlos E.; Griffiths, Elizabeth A.; Thompson, James E.; Brady, William E. 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 64 KB

P-301 Results of 5-azacitidine therapy i

P-301 Results of 5-azacitidine therapy in patients with myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML)

✍ Freyrie, A.; Reda, G.; Vincenti, D.; Ferla, V.; Orofino, N.; Sciumè, M.; Guidott 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 86 KB

A phase I dose escalation study of oral

A phase I dose escalation study of oral bexarotene in combination with intravenous decitabine in patients with AML

✍ Welch, John S.; Niu, Haixia; Uy, Geoffrey L.; Westervelt, Peter; Abboud, Camille 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 654 KB

O-021 Patterns of infection in patients

O-021 Patterns of infection in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) receiving 5-azacitidine. Candidates for antifungal prophylaxis

✍ Falantes, J.; Calderón, C.; Márquez-Malaver, F.J.; Aguilar, M.; Martino, M.L.; G 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 69 KB

A Phase 2 study of combination therapy w

A Phase 2 study of combination therapy with arsenic trioxide and gemtuzumab ozogamicin in patients with myelodysplastic syndromes or secondary acute myeloid leukemia

✍ Mikkael A. Sekeres; Jaroslaw P. Maciejewski; Harry P. Erba; Manuel Afable; Ricki 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 2 views

188 Chemotherapy-related infections in m

188 Chemotherapy-related infections in myelodysplastic syndromes (MDS) and acute myeloid leukemia secondary to MDS (sAML). A study of 27 patients

✍ I. Jarque; G.F. Sanz; L. Benlloch; L. Larrea; M. Arnao; P. Solves; J. Cervera; J 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 150 KB